Fund

Forebright Capital

光远投资

Forebright Capital (光远资本) is a Chinese investment firm that appears across elsewhere's corpus primarily as a co-investor and lead investor in growth-stage deals. In December 2020 it participated in MedSci Healthcare's nearly 2 billion yuan Series E1 alongside Tencent and 5Y Capital , and by mid-2023 it was leading rounds itself — notably the tens of millions of USD Series A for digital food tech company BOTINKIT (不停科技), where it invested through its 光远投资 vehicle . The BOTINKIT deal also saw follow-on from 5Y Capital and backing from professors associated with the XbotPark ecosystem including Li Zexiang . Beyond these two data points, elsewhere's corpus does not cover Forebright's fund structure, vintage, or broader portfolio in depth.

AI-generated — may contain errors, please verify.

Forebright CapitalFund
光远投资
渲染中…
Mentioned in 4 articles

Coverage